Search Results
Oct 17, 2025, 09:00 ET Curology Introduces DayPrimeRx- The first-ever prescription acne treatment and primer
the fact that acne treatments don't often layer well under makeup, forcing people to choose between cover and treat," said Dr. Whitney Tolpinrud, MD, FAAD, Board-Certified Dermatologist and Medical Director at Curology. "DayPrimeRx eliminates that choice, giving patients one product that immediately
More news about: Curology
Oct 17, 2025, 08:00 ET Rental affordability reaches four-year high
Baltimore, MD
More news about: Zillow
Oct 17, 2025, 08:00 ET Apnimed To Present Additional Phase 3 Data for AD109, an Investigational Oral Pill for Obstructive Sleep Apnea, at CHEST 2025 Annual Meeting
these findings is the improvement in oxygenation — a fundamental biomarker of how well the body is protected during sleep," said Patrick J Strollo, Jr., MD, study chair of the SynAIRgy clinical trial and Vice Chair of Medicine for Veteran's Affairs at the University of Pittsburgh School of Medicine. "In addition
More news about: Apnimed, Inc.
Oct 17, 2025, 02:00 ET Renalys Pharma Reaches Japan PMDA Agreement on Phase III Clinical Trials of Sparsentan for Focal Segmental Glomerulosclerosis (FSGS) and Alport Syndrome (AS)
Company Name: Renalys Pharma, Inc.Address: 3-11, Nihonbashi-honcho 2-chome, Chuo-ku, Tokyo, JapanRepresentative: BT Slingsby, MD, PhD, MPHEstablished: April 2023URL: https://renalys.com/
More news about: Renalys Pharma, Inc.
Oct 16, 2025, 20:00 ET ORVANA REPORTS Q4 FY2025 PRODUCTION AND EXPLORATION RESULTS FROM OROVALLE, SPAIN
issuers. For further information and detailed reconciliations, please see the "Non-GAAP Financial Performance Measures" section of the Company's latest MD&A. GEO were calculated using the following average market prices: Q4 FY2025: $3,455.50/oz Au, $39.38/oz Ag, $4.44/lb
More news about: Orvana Minerals Corp.
Oct 16, 2025, 19:24 ET NORDIC GROUP B.V. COMPARTE DATOS DEL GEL CANALICULAR LACRIFILL®
a mujeres destacadas en oftalmología y para impulsar nuestra misión de mejorar el entorno profesional para las oftalmólogas", declaró Lisa M. Nijm, MD, JD, consejera delegada de WIO y fundadora de Warrenville Eyecare & Lasik. Se invita a los asistentes a la AAO a visitar el
More news about: Nordic Pharma
Oct 16, 2025, 16:43 ET DIE NORDIC GROUP B.V. WIRD ÜBER IHRE TOCHTERGESELLSCHAFT NORDIC PHARMA, INC. (USA) IM RAHMEN DER AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2025 PATIENTENDATEN UND ERFAHRUNGSBERICHTE ZU LACRIFILL® CANALICULAR GEL, EINER NEUARTIGEN THERAPIE FÜR TROCKENE AUGEN, VERÖFFENTLICHEN
Jai Parekh, MD, MBA, kaufmännischer Leiter von Eye Care U.S. „Wir sind ständig bestrebt, Daten und Informationsmöglichkeiten bereitzustellen, die die Wirkung von LACRIFILL Canalicular Gel auf Patienten und Praxen belegen." Zu diesem Zweck wurden Vance Thompson, MD, Kayla Karpuk,
More news about: Nordic Pharma
Oct 16, 2025, 16:41 ET NORDIC GROUP B.V., PAR L'INTERMÉDIAIRE DE SA FILIALE NORDIC PHARMA, INC. (U.S.), PARTAGERA DES DONNÉES PATIENTS ET UNE ÉTUDE SUR L'EXPÉRIENCE DES PATIENTS AVEC LE GEL CANALICULAIRE LACRIFILL®, UN NOUVEAU TRAITEMENT POUR LA SÉCHERESSE OCULAIRE, PENDANT LA CONFÉRENCE 2025 DE L'ACADÉMIE AMÉRICAINE D'OPHTHALMOLOGIE (AAO)
Parekh, MD, MBA, directeur commercial chez Eye Care U.S. Nous nous efforçons en permanence de fournir des données et des opportunités de formation montrant l'impact du gel canaliculaire LACRIFILL sur les patients et les cabinets médicaux. » À cette fin, Vance Thompson, MD, Kayla
More news about: Nordic Pharma
Oct 16, 2025, 16:30 ET F.N.B. Corporation Reports Third Quarter 2025 Earnings
and other uncertainties described under Item 1A. Risk Factors and the Risk Management sections of our 2024 Annual Report on Form 10-K (including the MD&A section), our subsequent 2025 Quarterly Reports on Form 10-Q (including the risk factors and risk management discussions) and our other 2025 filings
More news about: F.N.B. Corporation
Oct 16, 2025, 16:24 ET REMAX NATIONAL HOUSING REPORT FOR SEPTEMBER 2025
+18.7%. The markets with the biggest decrease in year-over-year new listings percentage were Trenton, NJ at -38.3%, Dover, DE at -32.5%, and Baltimore, MD at -28.7%.
More news about: RE/MAX, LLC
Oct 16, 2025, 16:12 ET Dr. Joseph L. Wright, Leader in Advocacy and Health Equity, Honored at International Gathering of Child Safety Professionals
Death among Children in the U.S. NATIONAL HARBOR, Md., Oct. 16, 2025 /PRNewswire/ -- Joseph L. Wright, M.D., M.P.H., Senior Vice President and Chief Health Equity
More news about: Safe Kids Worldwide
Oct 16, 2025, 16:01 ET Surgeon, Speaker, Storyteller: Dr. Emilio Justo Champions Patience in a World That Won't Wait as He Announces the Launch of His New Book
challenge of raising a family. He doesn't preach; he teaches through patience and powerful reminders that lasting happiness cannot be rushed."Ruben Mesa, MD, President of Atrium Health Levine Cancer and Vice Dean at Wake Forest University School of Medicine, adds, "Dr. Emilio Justo has distilled his 'secret
More news about: Dr. Emilio Justo
Oct 16, 2025, 15:40 ET NYU Langone Health Rated Top-Quality Kidney, Liver & Lung Transplant Programs in New York
Robert Montgomery, MD, DPhil, the H. Leon Pachter, MD, Professor of Surgery, chair of the
More news about: NYU Langone Health
Oct 16, 2025, 15:30 ET NEW DIGITAL HEALTH VENTURE TACKLES CRITICAL MENTAL HEALTH CHALLENGES
workflows for providers focused on relapse prevention. The ReliefAI team has been great to work with in this collaboration.— Shaji Skaria MD, EVP Clinical Solutions VeeOne Health About ReliefAI Health, Inc.ReliefAI Health, Inc.,
More news about: LG Electronics USA
Oct 16, 2025, 13:59 ET Vivistim Co-Founder Named Innovator of the Year by the Congress of Neurological Surgeons
Paired VNS™ System for chronic stroke recovery, today announced that its co-founder and chief scientific officer, Navzer Engineer, MD, Ph.D., won the
More news about: MicroTransponder Inc.
Oct 16, 2025, 13:46 ET Microsoft extends AI advancements in Dragon Copilot to nurses and partners to enhance patient care
"The ecosystem Microsoft is creating with Dragon Copilot is essential for scalable innovation in healthcare," said Brett Oliver, MD, chief medical information officer for Baptist Health. "Rather than relying on isolated point solutions, we're able to adopt multiple tools — like Canary
More news about: Microsoft Corp.
Oct 16, 2025, 13:45 ET Smartphone-Based Relaxation Program Reduces Disability for Emergency Department Migraine Patients
Mia Minen, MD, MPH, associate professor in the Departments of
More news about: NYU Langone Health System
Oct 16, 2025, 13:38 ET Inner Circle acknowledges, Dr. Richard G. Linowes as a Pinnacle Professional Member Inner Circle of Excellence
GERMANTOWN, Md., Oct. 16, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Richard G. Linowes is acknowledged as a Pinnacle Professional Member Inner Circle of Excellence
More news about: The Inner Circle
Oct 16, 2025, 13:12 ET ImageTrend Announces New Medical Advisory Board Members
Brant-Zawadzki, MD, FAEMS – Unified Fire Authority and Utah's FEMA Urban Search & Rescue Task Force 1 Michael DePasquale, MD – Montgomery County Hospital District Puneet Gupta, MD, FACEP –
More news about: ImageTrend LLC
Oct 16, 2025, 12:35 ET Conversational AI Commerce Explodes Across Tech and Retail, Validating Foundational Patents of Inventor Stephen Byrd as Auction Clock Ticks
UPPER MARLBORO, Md., Oct. 16, 2025 /PRNewswire/ -- In a series of market-defining moves, the world's largest companies have signaled a massive and immediate shift towards conversational AI
More news about: Voicee LLC
Oct 16, 2025, 11:04 ET Tagworks Pharmaceuticals anuncia el inicio del ensayo clínico de fase 0/1 para TGW211
circulante tras la focalización tumoral, mejorar la relación dosis-tubo/sangre y reducir la exposición del tejido sano", afirmó el profesor James Nagarajah, MD, investigador principal del estudio en Radboudumc. "Nos enorgullece liderar la primera evaluación clínica de TGW211 y contribuir al avance de este enfoque
More news about: Tagworks Pharmaceuticals BV
Oct 16, 2025, 10:39 ET Tagworks Pharmaceuticals annonce l'autorisation du CTA et le début de l'essai clinique de phase 0/1 pour TGW211, un produit radiopharmaceutique pour le traitement des tumeurs HER2+
tumeur, en améliorant le rapport dose tumorale/dose sanguine et en réduisant l'exposition des tissus sains », déclare le professeur James Nagarajah, MD, chercheur principal de l'étude à Radboudumc. « Nous sommes fiers de mener la première évaluation clinique de TGW211 et de contribuer à faire progresser
More news about: Tagworks Pharmaceuticals BV
Oct 16, 2025, 10:26 ET Emergency Physicians Urge Vaccination During Flu Season
"Emergency physicians routinely manage patients with severe flu, which can lead to complications and hospitalization," said L. Anthony Cirillo, MD, FACEP, president of ACEP. "Flu vaccines are safe, effective, and one of the most important and accessible tools available to prevent severe illness."
More news about: American College of Emergency Physicians
Oct 16, 2025, 10:03 ET Less Politics, More Noodz: honeygrow Supports Federal Employees Weather the Shutdown Storm
customers across a wide range of lifestyles. honeygrow has more than 65 locations across the Northeast and Midwest in DE, MA, MD, NJ, NY, PA, VA, and OH. For more information about honeygrow, please visit www.honeygrow.com
More news about: honeygrow
Oct 16, 2025, 10:00 ET NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), TO SHARE PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, DURING AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2025
exciting!" said Jai Parekh, MD, MBA, Chief Commercial Officer of Eye Care U.S. "We are continually focused on providing data and educational opportunities showing the impact LACRIFILL Canalicular Gel has on patients and practices." To that end, Vance Thompson, MD, Kayla Karpuk, OD, and
More news about: Nordic Pharma